Studies had shown that SRXN1 was overexpressed in multiple types of malignancies, including cervical cancer,12 colorectal cancer,13 skin cancer,14 lung cancer,15 and renal cell carcinoma.16 This evidence concerns the gene SRXN1 and cervical cancer.